Low-dose CT observation of nonsolid lung nodules is safe.
Patients with nonsolid lung nodules can be safely followed with low-dose CT at 12-month intervals, according to a study published in Radiology.
Researchers from the United States and China studied the frequency of identifying nonsolid nodules, diagnosing lung cancer manifesting as such nodules, and the long-term outcome after treatment among 57,496 patients who participated in the International Early Lung Cancer Action Program.
The participants underwent baseline and annual repeat screenings, and the researchers evaluated the prevalence of nonsolid nodules and their effect on long-term outcomes. If a participant had more than one nonsolid nodule, the focus was on the largest.
"Nonsolid nodules could be due to inflammation, infection or fibrosis, but could also be cancerous or a precursor of cancer," co-author Claudia I. Henschke, PhD, MD, department of radiology at Mount Sinai School of Medicine in New York City, said in a release. "For screening, we have to define which nodules need further workup and how quickly we have to do that workup."
If a nodule increased in overall size or developed solid components, it was deemed to have grown. The findings showed that a nonsolid nodule was identified in 2,392 (4.2%) of the baseline screenings, which were ultimately diagnosed among 73 as adenocarcinoma.[[{"type":"media","view_mode":"media_crop","fid":"38866","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_3893409506277","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3902","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 148px; width: 300px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"CT images in a 68-year-old smoker show (a) a nonsolid nodule (17 x 13 mm) in the lef tupper lobe at baseline screening, (b) the nodule remained nonsolid at follow-up 2 years later, and (c) a solid component at follow-up 9 years later. At that time, it was resected, and the final diagnosis was 2.1-cm invasive adenocarcinoma. Image courtesy of Radiology. ©RSNA, 2015.","typeof":"foaf:Image"}}]]
A new nonsolid nodule was identified in 485 (0.7%) of 64,677 annual repeat screenings; 11 were diagnosed with stage I adenocarcinoma. Median time to treatment was 19 months and surgery was 100% curative in all cases, with a median follow-up since diagnosis of more than six years.
Treatment:
In 22 cases, the nonsolid nodule developed a solid component prior to treatment. Median transition time from nonsolid to part-solid was 25 months. No cancers occurred in new nodules 15 millimeters or larger in diameter.
"Many recommendations had been fairly aggressive with respect to nonsolid nodules," co-author David F. Yankelevitz, MD, also from Mount Sinai hospital, said in the same release. "These results show that there is no reason to be aggressive in pursuit of cancer, so long as the nodules stay in this nonsolid form."
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AMA Approves Category III CPT Codes for AI-Enabled Perivascular Fat Analysis from CT Scans
April 9th 2025Going into effect in 2026, the new CPT codes may facilitate increased adoption of the CaRi-Heart software for detecting coronary inflammation from computed tomography scans pending FDA clearance of the technology.
FDA Clears AI Assessment of Ischemic Core Volume on CT with Brainomix 360 Platform
April 8th 2025For patients with acute ischemic stroke, research has demonstrated that automated assessment of ischemic core volume on brain CT scans via the Brainomix 360 software is equivalent to that derived from CT perfusion.